"Progenza includes secretions from MSCs that improves viability and functionality of the cells during the freezing and thawing process. Regeneus has shown that a combination of cells and secretions has a more powerful therapeutic effect than cells alone."
RGS's secretions technology may turn out to be a unique product platform in regenerative medicine, and probably the key reason why AGC did a JV deal with Regeneus.
REG's secretions technology came in 2015 via a collaboration with Macquarie University.
http://www.mq.edu.au/newsroom/2015/...n-the-door-to-next-generation-cell-therapies/
Ann: Positive clinical trial results for Progenza, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
